Cogent Biosciences, Inc.

Ravi Kumar Jalluri

Mark Joseph Chicarelli

John Peter Fischer

Martha E Rodriguez

Logan E Vine

Jennifer Fulton

Bradley J Newhouse

Leah J Salituro

Aaron Christopher Smith

John E Robinson

Jay Bradford Fell

Macedonio J Mejia

Vijay Kumar

John I Trujillo

Yeyun Zhou

Cori A Malinky

Brooklynn Venteicher

Paul R Carlson

Patrick J Sutter

Payal Chatterjee

Scott W Niman

Tanna Bettendorf

Robert A Rieger

Lee M Stunkard

Michael L Conner

Hailey J Knox

A compound having the following structure of Formula (IV): or a stereoisomer, salt, or tautomer thereof, wherein R, R, R, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.

Compounds for FGFR inhibition

A compound having the following structure of Formula (I): or a stereoisomer of the compound, tautomer of the compound, pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, A, X, Z, and Y are as defined herein.Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.

PI3K inhibitors

Growing community of inventors

Boulder, CO, United States of America

Ravi Kumar Jalluri